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Population Council researchers are pioneering bold approaches to 
reducing sexually transmitted infections (STIs) and unintended pregnancy 
by developing a new generation of products, called multi-purpose 
prevention technologies (MPTs). These MPTs—gels, fast-dissolving inserts, and intravaginal 
rings—are designed to prevent HIV, other STIs, and/or unintended pregnancy simultaneously, allowing 
women and men to lead healthy sexual and reproductive lives.
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PC-1005 Gel
PC-1005 gel is the only 
candidate MPT designed for 
both vaginal and rectal use 
and to prevent HIV, HSV, and 
HPV simultaneously. Based 
on recent Phase 1 study data, 
PC-1005 Is safe for vaginal use. 
PC-1005 will undergo additional Phase 1 vaginal and 
rectal testing in 2017-18.
•	 PC-1005 contains a combination of MIV-150, zinc 
acetate, and carrageenan that provides broad-
spectrum antiviral activity.
•	 MIV-150, a highly potent antiretroviral drug that is 
effective against HIV.
•	 Zinc acetate, an antiviral that protects against HIV 
and HSV.
•	 Carrageenan, a seaweed-derived compound with 
highly potent activity against different types of 
HPV. Carrageenan also strengthens zinc’s activity 
against HSV.
•	 Innovative delivery systems for the drug 
combinations in PC-1005 may include sustained-
release intravaginal rings, or combining PC-1005 
with a SILCS diaphragm.
PC-9500 Fast-Dissolving Insert
The Population Council is 
collaborating with PATH to develop 
PC-9500, a candidate MPT designed 
for on-demand vaginal, and possibly 
rectal, use to prevent HIV, HSV, 
and HPV simultaneously. PC-9500 
contains a combination of griffithsin (GRFT) and 
carrageenan, providing broad-spectrum antiviral 
activity.
•	 GRFT is a naturally occurring algae-derived protein 
that inhibits HIV and other pathogens, including 
HSV.
•	 GRFT is the most potent anti-HIV agent described 
in the literature.
•	 GRFT could eliminate the risk of HIV drug cross-
resistance, because no other antiretroviral with 
similar mode of action is used in treatment.
•	 When combined with carrageenan, GRFT also 
inhibits HPV.
Intravaginal Ring
Council researchers are also 
developing an IVR to provide 
sustained-release protection from 
HIV, HSV, and HPV for up to 90 
days. FDI and IVR development will be supported by 
a Phase 1 safety and PK study of a GRFT gel, which 
is planned for 2017─18. This will be the first in-human 
study of a GRFT MPT.
